Publications
Journal Articles
Parkinson's Disease Psychosis and the Marketing of Pimavanserin
International Journal of Social Determinants of Health and Health Services
Are New Alzheimer Drugs Better than Older Drugs?
JAMA Internal Medicine
Challenging pharma: who cares?
Drug and Therapeutics Bulletin
A review of pharma-critical organizations, past and present.
Making the Case for Accelerated Withdrawal of Aducanumab
Journal of Alzheimer's Disease
Pharmaceutical marketing: the example of drug samples
Journal of Pharmaceutical Policy and Practice
Evergreened drugs or evergreened profits?
Journal of Evaluation in Clinical Practice
Patent extension tactics and their contribution to high drug costs.
Journal of American Dental Association
Pain Physician
A study showing that industry-funded continuing education on opioids misrepresents evidence and may increase, rather than decrease, opioid prescribing.
Industry-funded medical education is always promotion
British Medical Journal
A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough
Journal of General Internal Medicine
The Physician Payments Sunshine Act has not changed physician, consumer, or patient behavior.
The Benefits and Risks of Adherence to Medical Therapy
Journal of Scientific Practice and Integrity
An exploration of the reasons for noncompliance, and industry's stake in the issue.
Changing Pharmaceutical Industry Interaction in US Family Medicine Residencies: A CERA Study
Journal of the American Board of Family Medicine
Pharmaceutical Ethics and Grassroots Activism in the United States: A Social History Perspective
Journal of Bioethical Inquiry
An examination of public health activism in the Progressive Era, the postwar era and the present day.
Marketing Messages in Continuing Medical Education (CME) Modules on Binge-Eating Disorder (BED)
Journal of the American Board of Family Medicine
Marketing messages in continuing medical education promote drugs used to treat binge-eating disorder and underplay their risks.
Response: Re: Marketing Messages in Continuing Medical Education (CME) Modules on Binge-Eating Disorder (BED)
PharmedOut's response to Medscape's critique of Marketing Messages in Continuing Medical Education (CME) Modules on Binge-Eating Disorder (BED) further exposed industry marketing messages in Medscape's CME.
World Medical & Health Policy
A study on marketing messages in continuing medical education on fentanyl products.
How drug companies manipulate prescribing behavior
Colombian Journal of Anesthesiology
Discussion of common pharmaceutical industry tactics, from sales reps to CME to key opinion leaders, all to sway prescribers' opinions and therapeutic decisions.
Testosterone and sexual function
Current Opinion in Urology
Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia
PLoS One
Treating Aging with Testosterone
American Family Physician
Journal of Medical Ethics
Argues that a placebo-controlled trial is unethical when a treatment-controlled trial makes sense.
Pharmacist-industry relationships
International Journal of Pharmacy Practice
Treatment of Men for 'Low Testosterone': A Systematic Review
PLoS One
Salespeople in the Surgical Suite: Relationships between Surgeons and Medical Device Representatives
PLoS One
Why is a device rep in the OR and what does it mean for patient care?
Taking Sides: Should Ob/Gyns Prescribe Flibanserin for their Patients?
Contemporary OB/GYN
Saying no to this dangerous drug.
Direct-to-consumer Marketing to People with Hemophilia
PLoS Medicine
Exposing the relationships that drug manufacturers have with patients with hemophilia and their families.
American Journal of Nursing
CME stands for commercial medical education: and ACCME still won't address the issue
Journal of Medical Ethics
Hypoactive sexual desire disorder: inventing a disease to sell low libido
Journal of Medical Ethics
Society of Teachers of Family Medicine
Should Family Physicians Screen for Testosterone Deficiency in Men?
American Family Physicians
No: Screening may be harmful, and benefits are unproven.
Promoting to Everyone, Focusing on No One: The Illogical Promotion of the Influenza Vaccine
World Medical & Health Policy
The "everyone is at risk" message associated with universal influenza vaccination could undermine effective influenza prevention efforts.
How Basic Scientists Help the Pharmaceutical Industry Market Drugs
PLoS Biology
Physicians under the Influence: Social Psychology and Industry Marketing Strategies
Journal of Law, Medicine & Ethics
Pharmaceutical and medical device companies apply social psychology to subconsciously influence physicians' prescribing behavior.
PLoS Medicine
Journal of Continuing Education in the Health Professions
Assessing physicians' perceptions about industry relationships.
The Haunting of Medical Journals: How Ghostwriting Sold “HRT”
PLoS Medicine
How ghostwriting sold menopausal hormone therapy.
Do New Drugs Increase Life Expectancy?
Journal of General Internal Medicine
A critique of a Manhattan Institute paper.
Ethical considerations of publication planning in the pharmaceutical industry
Open Medicine
How industry uses medical writers to manipulate the medical literature.
Off-Label Promotion, On-Target Sales
PLoS Medicine
The covert promotion of drugs for unapproved uses.
Thus are our medical meetings managed
BMJ
Key opinion leaders may be unaware of pharma influence.
Prescription Tracking and Public Health
Journal of General Internal Medicine
Why the AMA's opt-out plan does not protect prescribing privacy.
Following the Script: How Drug Reps Make Friends and Influence Doctors
PLoS Medicine
Psychological techniques reps use to sell drugs.
Gynecologists and Estrogen: An Affair of the Heart
Perspectives in Biology and Medicine
Ob-gyns believe in HT despite evidence.
Doctors must not be lapdogs to drug firms
BMJ
Drug reps stomp out of a talk about industry influence.
"This may sting a bit": cutting CME's ties to pharma
Virtual Mentor (AMA Journal of Ethics)
CME should go pharma-free.
Advertising in Medical Journals: Should Current Practices Change?
PLoS Medicine
Taking ads for luxury goods would be less compromising to medical journals than accepting only drug ads.
Consumer Publications
Relyvrio debacle shows why FDA should stand its ground against conflicted advocacy groups
Cleveland Plain Dealer
Lilly's misleading marketing of Alzheimer's medicine
Pittsburgh Post-Gazette
Patient advocacy groups should stay out of drug approvals
The Baltimore Sun
The Supreme Court Justices Are Just Like Anyone Else
The Atlantic
Menopause is not a disability. Why are employers being asked to treat it like one?
The Baltimore Sun
Don't Give Symptom-Free People Alzheimer's Drugs
Hastings Bioethics Forum
Alzheimer's medicine a 'ray of hope'? That's marketing.
The Pittsburgh Post-Gazette
Heating up the hot flash market with unnecessary, and potentially harmful, drugs
The Baltimore Sun
Weighing the Consequences of Weight-Loss Drugs
MedPage Today
Why weight loss drugs are not the answer to obesity
KevinMD
Too soon to celebrate new Alzheimer's drug
The Baltimore Sun
Depriving women of this drug is good public health
KevinMD
Pittsburgh-Post Gazette
Opinion: Adding common-sense clarity to muddled CDC guidance
The Virginian Plot
CMS makes the right decision on Alzheimer's drugs | Opinion
Detroit Free Press
Op-ed: Cover hearing aids, not a questionable Alzheimer's drug
Chicago Tribune
Opinion: Caution warranted before using new Alzheimer's drug
The Detroit News
Do we all have Alzheimer's? Drug makers might want you to think so
The Baltimore Sun
Stop blaming Tuskegee study for Black vaccine hesitancy
The Detroit News
Mandate COVID-19 vaccinations in care facilities
Richmond Times-Dispatch
Bioethics Forum
There's trouble with tramadol that patients should know
The Columbus Dispatch
Patient Influencers Paid By Pharmaceutical Companies Should Be Required To Disclose Industry Ties
HealthAffairs
Vaping companies like mint, but not for the flavor
The Washington Post
Judy Butler & Adriane Fugh-Berman: Opioids are still overprescribed
The Pittsburgh Tribune-Review
As I See It: An industry report in government clothing
Worcester Telegram & Gazette
Industry-funded attacks on the CDC's opioid prescribing guidelines are eroding public health
STAT News
A New Treatment for Postpartum Depression: Boon or Bane?
Women's Health Activist (NWHN)
Another Voice: Drug companies should help pay for opioid harm
The Buffalo News
Is the opioid epidemic now the fentanyl epidemic?
The Baltimore Sun
Let the Sun Shine into the Medical Ivory Tower
Bioethics Forum
Bioethics Forum
Fentanyl at Your Door: Who are Pain Groups Advocating For?
The Hastings Center
Disclosing Corporate Funding Is Not Nearly Enough
The Chronicle of Higher Education
Women's Health Activist (NWHN)
Chicago Tribune
Rx for Change: Alternative Treatments for Chronic Pain
Women's Health Activist (NWHN)
Rx For Change: Obfuscating Opioid Risks
Women's Health Activist (NWHN)
Bioethics Forum
EpiPens are oversold and overused
South Florida Sun Sentinel
Bioethics Forum
How and why drug companies oversell the importance of EpiPens.
2016 Impacts Report on the Promotion of Diabetes Drugs in Washington DC
District of Columbia Department of Health
EpiPen Furor: Patient Groups Take Money, Stay Mum
Bioethics Forum
Women's Health Activist (NWHN)
Making an Example of Martin Shkreli
Bioethics Forum
Flibanserin and Regulatory Failure
Journal of Medical Ethics blog
Impact Ethics
The Drug That Cried "Feminism"
Bioethics Forum
Bioethics Forum
C-Section: my rights, my body, my baby
The Washington Post
LEGGO the Logo? Why Pharma Logos Belong on CME
Bioethics Forum
Women's Health Activist (NWHN)
Low T: Are Testosterone Treatments Safe and Effective for Men?
National Center for Health Research
Rounding Up Scientific Journals
Bioethics Forum
Outside Opinion: Testosterone treatments are dangerous for men
Chicago Tribune
Device Marketing To Doctors, In and Out of the OR
Women's Health Activist (NWHN)
Bioethics Forum
Mammography and the Corporate Breast
Bioethics Forum
Ghostwritten Articles Helped Sell Hormones
Women's Health Activist (NWHN)
Women's Health Activist (NWHN)
Deceptive Market Practices in the Marketplace of Ideas
Bioethics Forum
Help Your Doctor Break the Sample Habit
Women's Health Activist (NWHN)
Bioethics Forum
Hormones for Hot Flashes - Is "Natural" Better?
Women's Health Activist (NWHN)
Women's Health Activist (NWHN)
Bioethics Forum
Migraines, Menopause, and Marketing
Women's Health Activist (NWHN)
Unsafe IBS Drugs Back on the Market
Women's Health Activist (NWHN)
Cervical Cancer Vaccines and Industry Influence
Bioethics Forum
Women's Health Activist (NWHN)
Over-the-Counter Sales of Medical Records
Women's Health Activist (NWHN)
Cervical Cancer Vaccines in Context
Women's Health Activist (NWHN)
Less Hormone Therapy, Less Breast Cancer
Women's Health Activist (NWHN)
The Waiting Room: Pharma's Latest Lair
Bioethics Forum
Bioethics Forum
Big Pharma Wants to Know All About You
Women's Health Activist (NWHN)
A Bone to Pick with Bone Drugs
Women's Health Activist (NWHN)
Women's Health Activist (NWHN)
Why Race-Based Medicine is a Bad Idea
Women's Health Activist (NWHN)
WOMEN'S HEALTH ACTIVIST SEPTEMBER/OCTOBER 2005: PRESCRIPTION FOR CHANGE
Women's Health Activist (NWHN)